# REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study

> **NCT01247220** · PHASE2 · COMPLETED · sponsor: **Retina Associates of Florida, P.A.** · enrollment: 12 (actual)

## Conditions studied

- Macular Edema
- Branch Retinal Vein Occlusion

## Interventions

- **DRUG:** Ranibizumab
- **PROCEDURE:** Peripheral Laser

## Key facts

- **NCT ID:** NCT01247220
- **Lead sponsor:** Retina Associates of Florida, P.A.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01247220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01247220, "REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01247220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*